ganoderma lucidum mycelium extract est-il sûr pendant la grossesse ?
No harmonised CLP classification for reproductive toxicity (no H360/H361) and no CIR or SCCS safety assessment flagging reproductive hazards for Ganoderma lucidum mycelium extract. Peer‑reviewed literature describes pharmacology/immunomodulatory effects of Ganoderma constituents but does not provide convincing animal or human reproductive toxicity data relevant to topical cosmetic exposures (PubMed; PubChem; ECHA dossiers; CosIng). Therefore default hazard and mechanism scores are 0 and exposure from typical topical cosmetic use is judged negligible.
Related ingredients
Frequently asked questions
- ganoderma lucidum mycelium extract est-il sûr pendant la grossesse ?
- No harmonised CLP classification for reproductive toxicity (no H360/H361) and no CIR or SCCS safety assessment flagging reproductive hazards for Ganoderma lucidum mycelium extract. Peer‑reviewed literature describes pharmacology/immunomodulatory effects of Ganoderma constituents but does not provide convincing animal or human reproductive toxicity data relevant to topical cosmetic exposures (PubMed; PubChem; ECHA dossiers; CosIng). Therefore default hazard and mechanism scores are 0 and exposure from typical topical cosmetic use is judged negligible.
- ganoderma lucidum mycelium extract est-il sûr pendant l'allaitement ?
- As for pregnancy: no regulatory or peer‑reviewed evidence of reproductive or lactation hazards; dermal cosmetic use is expected to produce negligible systemic absorption for the high‑MW polysaccharide fraction and low systemic exposure for cosmetic use, so lactational exposure is unlikely (PubMed; CosIng; PubChem).
- ganoderma lucidum mycelium extract est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or dermal toxicity data. Hazard and mechanism remain 0 based on absence of evidence. Exposure is increased to 1 for baby skin because infant skin has higher permeability and surface‑area‑to‑weight, and although adult topical absorption is judged negligible, the ingredient is not wholly non‑absorbable (complex small triterpenes may penetrate), so infant exposure is plausibly low‑but‑measurable.
- Comment VeriMom évalue-t-il ganoderma lucidum mycelium extract ?
- VeriMom évalue ganoderma lucidum mycelium extract à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à ganoderma lucidum mycelium extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à ganoderma lucidum mycelium extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.